Description of Research Expertise:
Kidney transplant outcomes, Post-transplant diabetes mellitus, hepatitis C in kidney transplantation
Selected Publications:
Varga Alexandra N, Johnson David, Sawinski Deirdre L, Lim Mary Ann, Bloom Roy D, Abt Peter L, Goral Simin, Bleicher Melissa, Levine Matthew H, Naji Ali, Nazarian Susanna, Porrett Paige, Trofe-Clark Jennifer: Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients. Pharmacotherapy : 2018.
McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, Doshi SD, Abt P, Bloom R, Blumberg E, Kulkarni S, Esnaola G, Shults J, Thiessen C, Reese PP.: Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant.
Transplantation 102 (4): e163-e170,2018.
Lim MA, Kamili S, Cohen JB, Green-Montfort T, Tejada-Strop A, Kohli J, Drobeniuc J, Patel P, Vanderveen M, Bloom RD.: Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-Center Study.
Transplantation 102 (4): e126-e127,2018.
Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD: Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate Release Tacrolimus versus Extended Release Tacrolimus in African American Kidney Transplant Recipients
American Journal of Kidney Diseases 71 (3): 315-326,2018.
Potluri VS, Bloom RD: Treating Hepatitis C Virus in Patients with Advanced CKD in the Real-World: Time to Refocus on What Our Real Treatment Goals Should Be Kidney International : 2018.
Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O'Conner K, Reese P, Shelat K, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M: The American Society of transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation. American Journal of Transplantation 17 (11): 2790-2802,2017.
Hogan JJ, Lim MA, Palmer MB, Bloom RD, Chung RT, Sise ME: Development of proteinuria and focal segmental glomerulosclerosis during direct acting antiviral therapy for hepatitis C virus infection Hepatology 66 (2): 658-660,2017.
Bloom RD, Bromberg JS, Poggio E, Bunnapradist S, Langone A, Sood P, Matas A, Mehta S, Sharfuddin A, Fischbach B, Narayanan M, Jordan S, Cohen D, Hiller D, Prasad P, Woodward R, Grskovic M, Sninsky J, Yee JP and Brennan DC: Cell-free DNA and Active Rejection in Kidney Allografts Journal of the American Society of Nephrology 28 (7): 2221-2232,2017.
Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold J, Reese PP: Comparing outcomes between antibody induction therapies in kidney transplantation Journal of the American Society of Nephrology
28 (7): 2188-2220,2017.
Sawinski D, Patel N, Appolo B, Bloom RD: Use of HCV+ donors does not affect HCV clearance with directly acting antiviral therapy but shortens the wait time to kidney transplantation Transplantation 101 (5): 2017.